Analyst believes in continued progress for Ambu

When Ambu reveals its Q2 financial report on Wednesday morning, Sydbank analyst Søren Løntoft Hansen expects to see continued strong growth for single-use endoscopes.

Photo: Sydbank/PR

Ambu has had wind in its sails when it comes to the sale of single-use endoscopes, which may very well continue into the second quarter of the financial year 2020/2021.

However, the growth for the company's visualization business leg is hard to compare to the second quarter last year, Søren Løntoft Hansen, senior equity analyst at Sydbank warns.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs